QQ客服 官方微博 反馈留言

	BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells
	Lian, Guodong; Li, Leping; Shi, Yulong; Jing, Changqing; Liu, Jinglei; Guo, Xiaobo; Zhang, Qingqing; Dai, Tianyu; Ye, Fei; Wang, Yan 更多
刊名	INTERNATIONAL JOURNAL OF ONCOLOGY
	2018
卷号	52期号:3页码:804-814
关键词	gastric cancer polo-like kinase 1 inhibitor cisplatin protein pathway array synergistic
DOI	10.3892/ijo.2018.4255
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4577434
专题	山东大学
作者单位	Shandong Univ, Shandong Prov Hosp, Dept Gastrointestinal Surg, Ji
推荐引用方式 GB/T 7714	Lian, Guodong,Li, Leping,Shi, Yulong,et al. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells[J]. INTERNATIONAL JOURNAL OF ONCOLOGY,2018,52(3):804-814.
APA	Lian, Guodong.,Li, Leping.,Shi, Yulong.,Jing, Changqing.,Liu, Jinglei.,...&Wang, Yan 更多.(2018).BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.INTERNATIONAL JOURNAL OF ONCOLOGY,52(3),804-814.
MLA	Lian, Guodong,et al."BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells".INTERNATIONAL JOURNAL OF ONCOLOGY 52.3(2018):804-814.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。